Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1303)	1/7/2003 12:45:50 PM
From: tuck	Read Replies (1) \| Respond to of 1784

Wonder if this is good news for trickle in general, or just FSH in particular ( maybe not, since it would appear analysts already priced in the upside): >>8:36AM Fisher Scientific updates FY02, FY03 guidance (FSH) 30.04: Co expects EPS for 2002 to be "at the high end of its previously announced guidance range of $1.70 to $1.75" -- Multex consensus estimate is for earnings of $1.76 per share; says EPS for 2003 is expected to be between $2.10 to $2.15 -- Multex consensus estimate is for earnings of $2.12 per share.<< Cheers, Tuck